Volume | 5 |
|
|||||
News | - | ||||||
Day High | 279.49 | Low High |
|||||
Day Low | 279.49 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO.B | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
279.49 | 279.49 | 279.49 | 279.91 | 279.91 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
5 | 5 | - | 268.80 - 467.95 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:12:53 | 1 | US$ 280.02 | USD |
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO.B Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 279.75 | 279.91 | 268.80 | 279.91 | 45 | 0.16 | 0.06% |
1 Month | 331.38 | 342.68 | 268.80 | 310.89 | 95 | -51.47 | -15.53% |
3 Months | 321.02 | 357.67 | 268.80 | 333.30 | 328 | -41.11 | -12.81% |
6 Months | 273.00 | 357.67 | 268.80 | 327.78 | 209 | 6.91 | 2.53% |
1 Year | 464.48 | 467.95 | 268.80 | 338.03 | 131 | -184.57 | -39.74% |
3 Years | 631.85 | 879.00 | 268.80 | 501.98 | 110 | -351.94 | -55.70% |
5 Years | 298.88 | 879.00 | 268.80 | 461.56 | 155 | -18.97 | -6.35% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |